Saturday, January 31, 2026

North Korea’s New Destroyer Gets Stuck on the Ramp

North Korea's destroyer launch mishap angered Kim Jong Un, leading to investigations and potential delays in military deployment plans.

$100M Offers? OpenAI Staff Said ‘No Thanks’ to Meta’s Big Money

Sam Altman reveals Meta's failed attempts to recruit OpenAI talent despite offers of up to $100 million, highlighting corporate culture issues.

Intel Hit Hard as Trump Calls for Repeal of Semiconductor Subsidies

Trump's hints at repealing the semiconductor law caused Intel's stock to drop 2.44%, highlighting its reliance on government support.

Tag: Regeneron

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Top News

- Our Sponsors Ad -

Follow us